Neuroimmune and neurovirological aspects of human immunodeficiency virus infection
References (230)
- et al.
Nucleotide sequence and biological properties of a pathogenic proviral molecular clone of neurovirulent visna virus
Virology
(1993) - et al.
HIV and SIV gp120 binding does not predict coreceptor function
Virology
(1999) - et al.
gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats
Neuroscience
(1997) - et al.
Human astrocytes proliferate in response to tumor necrosis factor alpha
J. Neuroimmunol.
(1990) - et al.
HIV -1 gp120-induced neurotoxicity to midbrain dopamine cultures
Brain Res.
(1995) - et al.
Overexpression of nerve growth factor and basic fibroblast growth factor in AIDS dementia complex
J. Neuroimmunol.
(1999) - et al.
The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV 1-associated neurological diseases
J. Biol. Chem.
(1997) - et al.
A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes
Cell
(1997) - et al.
Neuronal loss in the frontal cortex in HIV infection [see comments]
Lancet
(1991) - et al.
Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia
J. Biol. Chem.
(1996)
Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid
J. Neuroimmunol.
(1989)
Loss of A1 adenosine receptors in human temporal lobe epilepsy
Brain Res.
(1996)
Selection of drug-resistant HIV
Trends Microbiol.
(1999)
Sustained increases in cerebrospinal fluid quinolinic acid concentrations in rhesus macaques (Macaca mulatta) naturally infected with simian retrovirus type-D
Brain Res.
(1990)
Human immunodeficiency virus-associated meningitis. Clinical course and correlations
Am. J. Med.
(1987)
Autoantibodies to phospholipids and to the coagulation proteins in AIDS
Thromb. Haemost.
(1997)
Interplays between mouse mammary tumor virus and the cellular and humoral immune response
Immunol. Rev.
(1999)
Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains
J. Clin. Invest.
(1993)
Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV -1 gp41
Science
(1996)
Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage
Neuropathol. Appl. Neurobiol.
(1999)
Neuronal apoptosis in HIV infection in adults
Neuropathol. Appl. Neurobiol.
(1995)
CC CKR5: a RANTES, MIP-1alpha, MIP-lbeta receptor as a fusion cofactor for macrophage-tropic HIV-1
Science
(1996)
Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription
Antimicrob Agents Chemother
(1996)
SCID mice with HIV encephalitis develop behavioral abnormalities
J. Acquir. Immune. Defic. Syndr Hum. Retrovirol.
(1998)
Cellular reservoirs of HIV -1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry
AIDS
(1996)
Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects
J. Infect. Dis.
(1993)
Infants, Children and Adolescents
AIDS: calcification of the basal ganglia in infants and children
Neurology
(1986)
Cytokines and HIV envelope glycoprotein gp120 stimulate Na+/H+ exchange in astrocytes
J. Biol. Chem.
(1994)
Cytokine circuits in brain: implications for AIDS dementia complex
Constitutive and visna virus induced expression of class I and II major histocompatibility complex antigens in the central nervous system of sheep and their role in the pathogenesis of visna lesions
Neuropatlaol. Appl. Neurobiol.
(1998)
Influence of neurologic manifestations of primary human immunodeficiency virus infection on disease progression. SEROCO Study Group
J. Infect. Dis.
(1995)
Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection
J. Immunol.
(1999)
Peripheral neuropathy in HIV-1 infection
Brain-derived HIV -1 tat sequences from AIDS patients with dementia show increased molecular heterogeneity
J. Neurovirol.
(1998)
Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection
Ann. Neurol.
(1990)
Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin
J. Infect. Dis.
(1996)
Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage
J. Infect. Dis.
(1997)
AIDS dementia complex and HIV -1 brain infection: clinical-virological correlations [see comments]
Ann. Neurol.
(1995)
Neuropathology of human immunodeficiency virus infection
Brain Pathol.
(1991)
V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1
J. Virol.
(1999)
Cerebral metabolite abnormalities correlate with clinical severity of HIV -1 cognitive motor complex
Neurology
(1999)
kappa opioid receptors in human microglia down- egulate human immunodeficiency virus 1 expression
Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures
Dev. Neurosci.
(1994)
Neuroinvasion by ovine lentivirus in infected sheep mediated by inflammatory cells associated with experimental allergic encephalomyelitis
J. Neurovirol.
(1998)
Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus
Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells and macrophages
J. Virol.
(1991)
Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism
J. Virol.
(1992)
The V3 domain of the HIV -1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection (see comments]
Nat. Med.
(1996)
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group
N. Engl. J. Med.
(1996)
Cited by (0)
Copyright © 2001 Published by Elsevier Inc.